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Zain Y. Khan1, Shanze Ashi1, Kehkashan Imtiaz1, Z. Aziz1, Faisal Malik1, John A. Lednicky3 
and Maureen T. Long2
1 Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan, 2 Department of Comparative 
Diagnostic and Population Medicine, College of Veterinary Medicine, University of Florida, Gainesville, FL, United States, 
3 Department of Environmental and Global Health, Emerging Pathogens Institute, University of Florida, Gainesville, FL, 
United States
Like most of the world, Pakistan has seen an increase in mosquito-transmitted diseases 
in recent years. The magnitude and distribution of these diseases are poorly understood 
as Pakistan does not have a nation-wide system for reporting disease. A cross-sectional 
study to determine which flaviviruses were causing of arboviral disease in Pakistan was 
instituted. West Nile virus (WNV) is a cause of seasonal fever with neurotropic findings in 
countries that share borders with Pakistan. Here, we describe the active and persistent 
circulation of WNV in humans in the southern region of Pakistan. This is the first report 
of WNV causing neurological disease in human patients in this country. Of 997 enrolled 
patients presenting with clinical features suggestive of arboviral disease, 105 were 
positive for WNV IgM antibodies, and 71 of these patients possessed WNV-specific 
neutralizing antibodies. Cross-reactivity of WNV IgM antibodies with Japanese enceph-
alitis virus (JEV) occurred in 75 of these 105 patients. WNV co-infections with Dengue 
viruses were not a contributing factor for the severity of disease. Nor did prior exposure 
to dengue virus contribute to incidence of neurological involvement in WNV-infected 
patients. Patients with WNV infections were more likely to present with altered mental 
status, seizures, and reduced Glasgow Coma scores when compared with JEV-infected 
patients. Human WNV cases and vector numbers exhibited a temporal correlation with 
climate.
Keywords: West nile virus, Dengue virus, Japanese encephalitis virus, encephalitis, arboviral disease
inTrODUcTiOn
West Nile virus (WNV) is a single-stranded, enveloped positive-sense RNA flavivirus that is main-
tained in nature by an enzootic cycle between birds and blood-feeding Culex mosquitoes (family 
Culicidae) (1). Culex spp. are widely distributed over the world and have been reported to feed on 
birds, humans, horses, and other mammals (2). Outbreaks of WNV disease have been reported 
in Europe, America, Africa, and parts of Asia (3–5). Serological evidence in humans and vector 
competence for WNV in Pakistan has been reported as early as 1982 (6, 7). In recent years, WNV has 
been identified in horses and humans in Pakistan and its neighboring countries, Iran, Afghanistan, 
and India as a cause of human encephalitic disease (8–13). Surveillance studies in these surrounding 
FigUre 1 | Locations of the patient enrollment sites in the Sindh region of 
Pakistan (8). Sites included medical colleges, teaching hospitals, and civil 
hospitals.
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countries report WNV circulation in several Culex species as well 
as several wild, migratory, and domestic birds and water fowl 
(14–19).
With the dissolution of the Pakistan Federal Ministry of 
Health in 2011, reporting and surveillance for arboviral diseases 
have become largely non-existent and, when performed, is 
highly localized and mostly funded by foreign granting agen-
cies. Pakistan is at a continual risk of suffering large epidemics 
of vector-borne diseases for a variety of reasons. Geopolitical 
instability, annual flooding, and poor health care infrastructure 
lead to frequent internal human and animal displacement. 
Moreover, the construction of super highways and shipping ports 
for efficient travel between Africa and China has left Pakistan 
vulnerable to the introduction of foreign diseases. Pakistan has 
recently witnessed an increased burden of arboviral infections, 
primarily from Crimean-Congo hemorrhagic fever virus, WNV, 
Chikungunya virus (CHIKV), and Dengue viruses (DENVs) 
affecting the economic, social, and political aspects of people’s 
lives (7, 20–22). More recently, active circulation of DENV, WNV, 
and CHIKV has been reported in humans living in the Punjab 
province of Pakistan (22).
Pakistan lacks a holistic surveillance system for arbovirus 
infections; therefore, there are limited data regarding types of 
vectors circulating, their temporal trends, and their correlations 
with climatic factors and human/animal cases. In light of the 
heightened alert of epidemic outbreaks and the global spread of 
arboviruses like WNV, CHIKV, and Zika virus, active surveillance 
for arboviruses in Pakistan is desperately needed for effective 
implementation of preventive and control strategies. Here, we 
present results of a multiyear seroprevalence and mosquito sur-
veillance project initiated in 2015 that analyzed human arboviral 
exposure, mosquito vectors, and their correlation with climatic 
factors.
MaTerials anD MeThODs
Patient enrollment
A cross-sectional, observational study was performed to identify 
which arboviruses [DENV, WNV, and Japanese encephalitis virus 
(JEV)] were the cause of acute undifferentiated febrile illness in 
selected basic health units and/or district hospitals of the Sindh 
region of Pakistan (8). Patients were enrolled under informed 
consent procedures, which were reviewed and approved by the 
Ethics Review Committee at Aga Khan University (3183-PAT-
ERC-14) and the Institutional Review Board at the University of 
Florida (201500908). All enrolled subjects gave written informed 
consent in accordance with the Declaration of Helsinki. Patients 
presenting with the CDC clinical description of arboviral dis-
ease including findings of rash, headache, arthralgia, myalgia, 
gastrointestinal distress, acute hemorrhagic fever, acute flaccid 
paralysis, encephalitis, meningitis, and/or unexplained fever 
were recruited (23). Patients younger than 10 years and older 
than 90  years were excluded. Briefly, all patients were tested 
for DENV NS1 antigen unless affected primarily by neurologic 
abnormalities. All NS1-negative sera were evaluated for expo-
sure to WNV or JEV via IgM capture ELISA for JEV and WNV. 
Five study sites were established, and personnel were trained 
throughout the Sindh province in Pakistan (Figure 1) (8). These 
sites included medical colleges, teaching hospitals, and civil 
hospitals.
Diagnostic criteria
Patients were confirmed positive for virus exposure according to 
CDC criteria, which requires “virus-specific IgM antibodies in 
serum with confirmatory virus-specific neutralizing antibodies 
in the same or a later specimen” (23). Patients were classified as 
a suspect case if they had virus-specific IgM antibodies in serum 
but with a neutralizing titer of less than 50% at the highest con-
centration of serum. For cross-reactive specimens, patients were 
confirmed positive when they had virus-specific IgM antibodies 
and neutralizing antibodies in the same specimen that exhibited 
the highest level of neutralization for one of the viruses in ques-
tion. Cross-reactive patients were classified as suspect according 
to the greatest amount of virus-specific IgM antibodies. Patients 
were considered positive for DENV co-infection if they had 
DENV-specific NS1 antigen. Patients were considered as having 
prior DENV exposure if they exhibited greater than 80% neutrali-
zation at the 1:2560 serum dilution.
ns1 and igM elisa Testing for 
Flaviviruses
Primary DENV screening in patients was performed using 
a commercial ELISA (Panbio Dengue Early Rapid Test NS1 
antigen capture test, Alere, Waltham, MA, USA) following 
manufacturer’s instructions. For WNV and JEV, a commercial 
IgM capture ELISA for work with diagnostic specimens in BSL-2 
facilities (InBios WNV Detect™ and JEV Detect™, InBios, 
Seattle, WA, USA) was used following the manufacturer’s 
instructions.
FigUre 2 | Locations of the mosquito traps used for vector collection, May–November 2015. Sites were selected based on their close vicinity to trees/shrubbery, 
water, and human activity. The area encompassed 0.34 km2 and included high-rise buildings, lakes, water pools, and green patches.
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rT-Pcr
West Nile virus and JEV primers and probes were used to detect 
the NS2 gene (24). The samples of all WNV and/or JEV IgM-
positive samples and mosquito pools were screened. Briefly, RNA 
was isolated from mosquito pools, human CSF (where received, 
patients with neurological symptoms only), and serum samples 
using a commercial virus RNA extraction kit (QIAamp viral RNA 
kit, Qiagen, Valencia, CA, USA). Mosquito pools were homog-
enized in PBS to form a 1:10 (v/v) homogenate using sterile 
pestles in 1.5-ml polypropylene tubes. All samples were stored 
at −80°C until use.
RNA was reverse transcribed to cDNA (iScript cDNA 
Synthesis Kit, Bio-Rad, Hercules, CA, USA), and PCR was per-
formed. For the WNV PCR, 1,000  nM of forward and reverse 
primers and 200 nM of fluorogenic probe were used, and for the 
JEV PCR, 375 nM of forward and reverse primers and 250 nM of 
fluorogenic probe were used (Biosearch Technologies, Petaluma, 
CA, USA) in a 20-µl total reaction volume. Standard cycling 
conditions consisted of once at 95°C for 2 min followed by 40 
cycles of 95°C for 15 s and 60°C for 1 min.
Plaque reduction neutralization Testing 
(PrnT)
A PRNT was performed to determine the neutralizing capacity 
of patient serum. Viruses used included the following: WNV 
(NY99), DENV-1 (TS-SMAN), DENV-2 (NGC), DENV-3 
(H87), DENV-4 (H241), and JEV (SA-14-8). All PRNT assays 
were performed side by side under BSL-3 containment to ensure 
continuity of data. Four-fold dilutions of heat-inactivated patient 
serum were mixed with an equal volume of MEM (Corning, 
Tewksbury, MA, USA) containing ~50–100 plaque-forming 
units of virus and incubated for 1 h at 37°C. After incubation, 
this mixture was inoculated onto confluent Vero E6 cells in 
12-well plates, which were then incubated for 1 h at 37°C. After 
incubation, the inoculum was removed; and an overlay of MEM 
with 0.5% wt/vol methylcellulose, 2.5% FBS, non-essential amino 
acids, penicillin, streptomycin, and amphotericin B was added to 
the wells; and the plates were incubated until plaques were visible 
(3–10  days). For visualization of plaques, the methylcellulose 
overlay was removed, and cells were stained with a fresh mixture 
of 50% methanol, 43% ethanol, 7% acetic acid, and 0.1% wt/vol 
Comassie blue and plaques were counted. The antibody titer was 
determined as the highest serum dilution that neutralized 50% of 
the virus inoculum.
Vector surveillance
Eight sites (1–8) were selected in Karachi for mosquito trap place-
ment (Figure 2) based on their close vicinity to trees/shrubbery, 
water, and human activity. The area was spread over 0.34  km2 
and landscaped with high-rise buildings, lakes, water pools, and 
intermittent green patches. The average distance between the sites 
was 200 m.
Three types of mosquito traps were used including the CDC 
Miniature Light Trap (Model 512), the BG-Sentinel™ (Biogents 
GmbH, Regensburg, Germany) and the CDC Gravid trap (John 
W. Hock Company, Gainesville, Florida, model 171). The traps 
were set per manufacturers’ recommendations. The CDC light 
FigUre 3 | Number of patients with both West Nile virus (WNV)-specific IgM and neutralizing antibodies. Data include patient specimens from all five study sites 
over a 2-year period.
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trap was hung approximately 2  m above the ground. The BG 
sentinel trap was baited with the BG-Lure attractant supplied by 
the manufacturer and placed near an area sheltered from wind 
and direct sunlight. The Gravid Trap infusion was prepared by 
adding 3 l of water to dry grass hay. These traps were connected 
to a 12 V rechargeable battery.
Mosquito surveillance activity began in May 2015 and ended 
in November 2015. Traps were placed near identified locations for 
four consecutive nights (Monday to Thursday) from 4:00 p.m. to 
9:00 a.m. Each set of traps was placed at one site for 1 week and 
then rotated to another site. The mosquitoes were collected daily 
and taken directly to the research laboratory, and mosquitoes 
were placed on a chilled Petri dish and separated and differenti-
ated according to sex and species. Female mosquitoes species 
were further separated according to blood and non-blood fed. All 
identified mosquitoes were quantified and aliquoted and stored 
at −80°. For each RT-PCR reaction, RNA was extracted from 
individual pools of 30 mosquitoes. Mosquito grinding and RNA 
extraction was performed using Qiagen viral RNA extraction kit.
environment Monitoring of Temperature 
and humidity charts
The Pakistan Meteorological Department, Karachi head-office 
graciously shared their daily temperature, humidity, and pre-
cipitation monitoring data. Mean temperature, humidity, and 
precipitation were calculated and recorded. Monthly data compi-
lations were correlated with the number of mosquitoes collected 
from traps and confirmed human WNV cases.
statistical analysis
Statistical analyses were performed on clinical data using 
MedCalc version 17.9.7—64-bit. Logistic regression for 
dichotomous independent variables was performed. Odds ratios 
were calculated with 95% confidence intervals. Ratios with a p 
less than 0.05 were considered significant. Pearson’s correlation 
coefficients, and associated p values were calculated to identify 
potential relationships between different variables in the data set.
resUlTs
WnV is a cause of Febrile illness in 
Patients with Undifferentiated Fever in 
Pakistan
West Nile virus exposed patients were enrolled from all five sites 
beginning in May 2015 and continuing through December 2016 
(Figure 3). Peaks in human case were observed during September 
and October, which is consistent with the incidence of WNV 
reported in other endemic areas like Europe, the United States, 
and the Mediterranean region (Figure  3). Clinical specimens 
were confirmed positive based on the CDC guidelines that require 
detection of virus-specific IgM antibodies with virus-specific 
neutralizing antibodies in the same or later specimen (23). Of 
a total of 997 patients enrolled, based on the CDC criteria for 
clinical manifestations of arboviral disease, 105 patients tested 
positive for WNV IgM. Twenty-eight (26.6%) of these patients 
were positive for WNV IgM only (Table S1 in Supplementary 
Material). Seventy-nine (75.23%) patients exhibited positive IgM 
for both WNV and JEV (Table S1 in Supplementary Material). 
Eight (7.5%) of these patients were also positive for DENV NS1 
antigen (Table S1 in Supplementary Material).
The 105 samples that were positive for WNV IgM were evalu-
ated for neutralizing antibodies specific for JEV and WNV via 
PRNT. Thirty-six (33.96%) exhibited greater neutralization for 
Table 1 | Incidence of symptoms of suspect and confirmed West Nile virus (WNV)-positive patients compared to WNV-negative patients presenting with clinical 
features suggestive of arboviral disease.
symptom WnV confirmed (n) WnV igM+ (n) WnV confirmed, Or (95% ci) WnV suspect, Or (95% ci)
Male 67% (40) 73.5% (64) 0.54 (0.22–1.31) 0.24 (0.05–1.13)
Eye pain 8.4% (5) 9% (8) 1.33 (0.30–5.87) 1.59 (0.18–13.79)
Fever ≥ 38°C 44% (26) 43.6% (38) 1.33 (0.61–2.90) 1.52 (0.55–4.25)
Hemorrhage 18.6% (11) 19.5% (17) 2.09 (0.68–6.44) 4.11 (0.51–33.12)
Rash 11.8% (7) 23.7% (14) 1.24 (0.44–3.52) 0.74 (0.21–2.56)
Nausea 47.4% (28) 59.7% (52) 0.40 (0.18–0.89) 0.29 (0.09–0.95)
Headache 42.3% (25) 43.5% (38) 1.04 (0.48–2.28) 1.29 (0.46–3.61)
Myalgia 35% (21) 42.5% (37) 0.66 (0.30–1.45) 0.89 (0.33–2.46)
Arthralgia 15% (9) 13.8% (12) 1.48 (0.46–4.75) 0.78 (0.19–3.13)
Hypertension 10.7% (6) 16% (14) 0.89 (0.29–2.68) 0.54 (0.15–1.93)
Altered mental status 28.3% (17) 24% (21) 4.25 (1.32–13.69) 5.45 (0.68–43.44)
Seizures 15% (9) 13.8% (12) 2.58 (0.66–10.14) 2.64 (0.32–21.79)
Limb weakness 5% (3) 6.9% (6) 0.56 (0.12–2.65) 0.52 (0.09–2.93)
Encephalitis 21.7% (13) 22.9% (20) 1.62 (0.62–4.24) 2.75 (0.59–12.88)
Thrombocytopenia 61.7% (37) 71.2% (62) 0.55 (0.23–1.31) 0.36 (0.09–1.34)
Lymphocytosis 33.3% (20) 36.8% (32) 1.17 (0.52–2.65) 0.68 (0.24–1.87)
Reduced Glasgow Coma Scale 10.7% (6) 10.7% (9) 1.96 (0.48–8.06) 423E + 006
Any neurological symptom 40.7% (24) 47.1% (41) 1.65 (0.75–3.62) 3.58 (1.10–11.66)
Elevated AST 92.6% (25) 61% (63) 0.95 (0.80–1.12) 2.00 (0.49–8.24)
Elevated ALT 68.4% (26) 62.5% (42) 1.2 (0.47–3.34) 1.05 (0.83–1.13)
Patients with both WNV-specific IgM and neutralizing antibodies were considered confirmed, and patients with only IgM antibodies were considered suspect. Bold values indicate 
statistical significance for the odds ratio (p < 0.05).
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WNV than JEV when the minimum neutralization was set at 
80% (Table S1 in Supplementary Material). Fifty-nine (55.66%) 
patients exhibited greater neutralization of WNV than JEV when 
the minimum neutralization was decreased to 50% (Table S1 in 
Supplementary Material). In the absence of neutralizing antibod-
ies, patients were classified as probable exposures for the virus for 
which they possessed the highest IgM activity. Seventeen (16.1%) 
individuals had greater neutralizing activity for JEV than WNV 
(Table S1 in Supplementary Material). Twenty-nine (27.36%) 
patients did not exhibit significant neutralization of either WNV 
or JEV (Table S1 in Supplementary Material). CSF samples from 
two patients who presented with signs and symptoms suggestive 
of viral encephalitis/meningitis were tested by RT-PCR for WNV; 
however, none of the samples were positive for WNV (data not 
shown).
clinical Features of human WnV infection
Of the 105 WNV IgM-positive patients, 61.9% were male (n = 65; 
Table 1). The mean age was 31 years; however, patients from 10 
to 86 were enrolled (data not shown). Clinical findings at time of 
presentation included headache, body ache, and nausea/vomiting 
and were seen in most patients enrolled. The average duration of 
fever at time of presentation was 4 (±2) days. Thirty-nine (n = 41) 
presented with signs and symptoms suggestive of central nervous 
system (CNS) involvement that included altered consciousness, 
vertigo, seizures, limb weakness, decreased Glasgow Coma 
scores, and encephalitis (Table 1). For the sake of simplifying data 
analysis, acute disseminated encephalomyelitis, meningitis, and 
meningoencephalitis were all classified as encephalitis.
Although males comprised 73.5% of the WNV IgM positive 
and 67% of the WNV confirmed population, this variable was 
not significant (Table 1). Clinical symptoms suggestive of WNV 
neuroinvasive disease were not always indicative of WNV expo-
sure. WNV confirmed individuals were 4.25 times more likely 
to present with altered mental status (p = 0.0058) and twice as 
likely to have seizures, hemorrhage, and encephalitis (Table 1). 
Other symptoms of WNV neuroinvasive disease such as stiff 
neck, vertigo, limb weakness, and reduced Glasgow Coma Scale 
were not significant predictors of exposure and were just as 
likely to be observed in individuals negative for WNV exposure 
(Table 1). Over half of WNV-exposed individuals were younger 
than 30 years, and 82% were younger than 40 years (Figure 4). 
Although most patients with encephalitis were in the 20–30 age 
group, the percentage of encephalitis was highest in the very 
young or in the 50–60 and 60–70 age groups (Figure 4).
When comparing the symptoms of WNV- and JEV-exposed 
individuals, several features were unique for each virus. Patients 
with JEV exposure were 7.16 times more likely to present with 
GI distress including nausea and vomiting (p = 0.0053) and 5.5 
times more likely to be male (p = 0.0445; Table 2). Persons with 
JEV exposure were also nearly five times more likely to exhibit 
thrombocytopenia than WNV-exposed patients (p  =  0.0438; 
Table  2). However, altered mental status was not reported for 
patients with JEV exposure and was 4.25 times more likely to be 
identified in patients with WNV exposure (p = 0.043; Table 2).
Unfortunately, immune status ratios (ISRs) for the WNV 
and JEV IgM kits did not correlate with neutralization via 
PRNT (p = 0.76 WNV, p = 0.12 JEV; Table S1 in Supplementary 
Material). Many WNV and JEV ISR values indicated positive 
exposure, but the samples had little to no neutralizing activity 
(Table S1 in Supplementary Material). Moreover, several WNV 
ISR values indicated WNV exposure, but when assayed via 
PRNT, these patients had greater neutralizing activity for JEV 
than WNV (Table S1 in Supplementary Material). In the absence 
of neutralizing antibodies, specimens were classified as suspect/
FigUre 4 | continued
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probable exposure based on whichever virus exhibited the great-
est ISR values.
WnV and JeV igM responses are highly 
cross-reactive
A subset of 28 patients with JEV and WNV IgM antibodies were 
evaluated for neutralization of DENV. These patients were all 
positive for WNV, DENV, and JEV IgM. PRNTs were performed 
for these patients against DENV 1-4, WNV, and JEV (Table S1 
in Supplementary Material). All but three patients had at least 
80% neutralizing activity against at least one DENV serotype at 
antibody titers of 1:40 (Table S1 in Supplementary Material). Two 
of the three non-DENV neutralizing patients did not exhibit neu-
tralizing activity against WNV or JEV despite having encephalitis 
Table 2 | Incidence of symptoms in West Nile virus (WNV) and Japanese encephalitis virus (JEV) confirmed cases in patients presenting with clinical features 
suggestive of arboviral disease.
symptom WnV confirmed (n) JeV confirmed (n) WnV Or (95% ci) JeV Or (95% ci)
Male 67% (40) 94.4% (16) 0.54 (0.22–1.31) 3.5 (0.75–16.36)
Eye pain 8.4% (5) 5.9% (1) 1.33 (0.30–5.87) 0.73 (0.08–6.29)
Fever ≥ 38°C 44% (26) 35% (6) 1.33 (0.61–2.90) 0.82 (0.28–2.36)
Hemorrhage 18.6% (11) 5.9% (1) 2.09 (0.68–6.44) 0.28 (0.03–2.27)
Rash 11.8% (7) 23.5% (4) 1.24 (0.44–3.52) 1.6 (0.46–5.64)
Nausea 47.4% (28) 94.4% (16) 0.40 (0.18–0.89) 7.16 (1.54–33.21)
Headache 42.3% (25) 41% (7) 1.04 (0.48–2.28) 0.72 (0.24–2.11)
Myalgia 35% (21) 41% (7) 0.66 (0.30–1.45) 1.06 (0.37–3.05)
Arthralgia 15% (9) 11.8% (2) 1.48 (0.46–4.75) 0.84 (0.17–4.16)
Hypertension 10.7% (6) 17.6% (3) 0.89 (0.29–2.68) 1.36 (0.34–5.44)
Altered mental status 28.3% (17) 0% (0) 4.25 (1.32–13.69) 7.68E–010
Seizures 15% (9) 0% (0) 2.58 (0.66–10.14) 2.37E–009
Limb weakness 5% (3) 11.8% (2) 0.56 (0.12–2.65) 0.85 (0.09–7.58)
Encephalitis 21.7% (13) 5.9% (1) 1.62 (0.62–4.24) 0.19 (0.02–1.5)
Thrombocytopenia 61.7% (37) 94.4% (16) 0.55 (0.23–1.31) 3.94 (0.85–18.42)
Lymphocytosis 33.3% (20) 41% (7) 1.17 (0.52–2.65) 1.4 (0.48–4.06)
Reduced Glasgow Coma Scale 33.3% (20) 0% (0) 1.65 (0.75–3.62) 2.40E–009
Any neurological symptom 40.7% (24) 41% (7) 0.95 (0.80–1.12) 0.13 (0.03–0.62)
Elevated AST 10.7% (6) 71.4% (10) 1.2 (0.47–3.34) 0.57 (0.14–2.31)
Elevated ALT 40.7% (24) 73.3% (11) 0.79 (0.21–2.99) 0.95 (0.74–1.22)
Dengue/WNV co-infection and neurological symptoms 14.8% (4) 2.16 (0.4–11.74)
Prior Dengue viruses exposure WNV neuroinvasive disease 11% (3) 0.18 (0.03–0.99)
Patients with both virus-specific IgM and neutralizing antibodies were considered confirmed. For cross-reactive patients, exposure was confirmed for the virus with the greatest 
Plaque Reduction Neutralization Testing titer. Bold values indicate statistical significance (p < 0.05).
FigUre 4 | A graphical representation of how WNV infections (a), WNV encephalitis (b), and percentage of cases with neurological symptoms (c) occurred in 
different age groups.
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and limb weakness and positive IgM antibodies (Table S1 in 
Supplementary Material). The remaining patient had neutral-
izing antibodies to WNV only and presented with altered mental 
status and meningitis. Sixteen of the 28 patients exhibited sero-
logical profiles indicative of prior DENV infections with DENV 
neutralization of at least 80% at the 1:2560 serum dilution (Table 
S1 in Supplementary Material). Three of these patients exhibited 
symptoms of neuroinvasive disease, but having prior exposure 
to DENV was not a contributing factor (p =  0.0238; Table S1 
in Supplementary Material). Here again, DENV ISR values did 
Table 3 | Numbers, species, and sex of mosquitoes caught in three types of 
trap.
Trap genus Male Female Total
CDC gravid Culex 2,466 3,365 5,831
BG sentinel Culex 1,566 1,315 2,881
CDC light Culex 62 91 153
CDC gravid Anopheles 9 18 27
BG sentinel Anopheles 14 13 27
CDC light Anopheles 0 0 0
CDC gravid Aedes aegypti/Aedes albopictus 1 6 7
BG sentinel A. aegypti/A. albopictus 2 3 5
CDC light A. aegypti/A. albopictus 0 0 0
FigUre 5 | Correlation of human West Nile virus cases, vector abundance, and average monthly temperatures in Karachi, Pakistan.
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not correlate with neutralizing activity (p  =  0.2931 DENV1, 
p =  0.3157 DENV2, p =  0.4099 DENV3, p =  0.6602 DENV4) 
nor were the ISR values dependent on whether the patient had a 
primary or secondary DENV exposure (p = 0.9861; Table S1 in 
Supplementary Material).
DenV/WnV co-infections are associated 
with neurological symptoms
Dengue virus NS1 antigen was detected in eight patients with 
WNV-specific IgM and neutralizing antibodies. Four patients 
exhibited symptoms of neuroinvasive disease and were twice 
as likely to exhibit neurological symptoms than patients 
without DENV co-infection (Table S1 in Supplementary 
Material).
Vector abundance correlates with 
Temperature and Precipitation
Temperature recordings for Karachi during 2015 showed an 
increase in temperatures in May through October with aver-
age temperatures between 31 and 30°C. Peak temperatures 
occurred in June (average  =  33C°; Figure  5). During this 
period, Karachi experienced the worst heat wave on record 
for June with temperatures reaching 43°C. During this time, 
significantly fewer mosquitoes were collected (Figure 5). The 
average humidity showed an upward trend starting in May 
that continued through October. During November, Karachi 
experienced a fall in average temperatures by 3–4° and a drop 
in relative humidity by 20% compared to the preceding months 
(Figure 5).
The average number of mosquitoes collected in the traps cor-
related with peak temperatures of the city when the heat waves 
were subtracted from the analysis (r = 0.8067) (Figure 4). A total 
of 8,931 mosquitoes were collected during the study period. The 
majority of mosquitoes belonged to the Culex species (Table 3). 
47.5% of the total number of mosquitoes were male Culex, while 
female Culex represented 51.8% of the total (Table 3). Anopheles 
(male 0.27%; female 0.34%) and Aedes (male 0.03%; female 
0.097%) species accounted for very small percentages of the total 
(Table 3). Mosquito numbers were lowest in the months of May 
and June (n  =  52); however, numbers increased significantly 
during July (n =  984) and August (n =  1,110) with a peak in 
September (n =  2,434) and October (n =  3,553; Figure  5). A 
sharp decline in mosquito numbers was recorded in November 
(n = 1,125; Figure 5). It was during the month of September that 
WNV was detected in a pool of 30 Culex mosquitoes that were 
trapped at location 8 (Figure 2), which is near the entrance to the 
offices for the Aga Khan University Hospital.
Of the three types of traps used in this study, the CDC Gravid 
Trap was the most successful in capturing Culex spp., catching 
65.7% of all Culex spp. (Table 3). This was twice as effective as the 
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BG Sentinel and 38 times more effective than the CDC light Trap 
(Table 3). For Anopheles and Aedes species, the CDC Gravid Trap 
and the BG-Sentinel performed the same (Table  3). The CDC 
Light Trap did not capture any Anopheles or Aedes species and 
overall was the least successful, contributing only 2% to the total 
number of mosquitoes caught (Table 3).
DiscUssiOn
Diagnosis and appropriate treatment of arboviral disease is prob-
lematic in areas where these pathogens co-circulate. Overlapping 
clinical presentation combined with serological cross-reac-
tivity render definitive diagnosis expensive and cumbersome. 
Furthermore, secondary infections with these types of viruses 
can exacerbate clinical symptoms and complicate interpretation 
of diagnostic tests. Laboratory confirmation remains a major 
challenge, and RT-PCR is not very useful in diagnosis of WNV 
or JEV as viremia occurs 3–4  days before the onset of clinical 
symptoms. Given that DENV, JEV, and WNV are flaviviruses, 
there is serological cross-reactivity and absolute confirmation 
requires the most cumbersome and highly skilled plaque reduc-
tion assay. This type of infrastructure is lacking in many labs and 
medical facilities in Pakistan.
The data herein emphasize that viral IgM is not indicative of 
exposure. Patients positive for JEV IgM were usually positive for 
WNV IgM and vice versa. Even more troubling was that these 
cross-reactive samples were also invariably positive for DENV 
IgM (Table S1 in Supplementary Material). It was also impossible 
to achieve a diagnosis based on the IgM activity alone as ISR 
values were often very close in value and could not be directly 
compared between viruses due to test composition and result 
parameters. Analysis of the PRNT data showed no correlation 
between IgM activity with neutralizing activity. There was also 
no correlation between IgM positivity and PRNT positivity at any 
serum dilution. As most of the epidemiological data being gener-
ated from lower- and middle-income countries is based on IgM 
diagnostics, without further confirmatory testing or collection of 
convalescent serum, this raises questions as to the true prevalence 
for these viruses.
Similar diagnostic issues were present for neutralizing anti-
bodies as most patients exhibited some level of neutralization for 
WNV, JEV, and DENV 1–4. Similar neutralizing activity has been 
reported for DENV and Zika virus, WNV and Murray Valley 
encephalitis virus, JEV with DENV 1–4, and Yellow fever virus 
with WNV, DENV, and tick-borne encephalitis virus (25–28). We 
also noted a large background of prior DENV exposure indicated 
via highly neutralizing PRNT titers, which mirrors what has been 
reported in other studies examining flaviviral cross-reactivity 
(26, 28).
When following the CDC/WHO diagnostic algorithms for 
arboviral disease, cross-reactivity devalues their use if IgM 
ELISA and PRNT are used as diagnostic tools. As stated by 
Lee et al. “Prior to the introduction of Zika to the Americas, 
PRNT was considered the gold standard of serological assays” 
(26). Cross-reactive samples used to be diagnosed as “flavivirus 
exposed” or some other generic classification. Since effective 
treatments are not available for most flavivirus infections, a 
definitive diagnosis was not viewed as significant as it is grow-
ing to be. Emerging data documenting debilitating sequelae 
including arthralgia and neurological issues, the development 
of neurodegenerative disorders, and horrific congenital conse-
quences emphasize the need for rapid and accurate diagnostics 
to drive decisions and reassure patients and health care provid-
ers (26, 29–33).
Dengue viruses are endemic in Pakistan, and as such, many 
patients enrolled in this study were diagnosed as having DENV 
fever by physicians although neurological symptoms were pre-
sent. It is not uncommon for DENV to co-circulate WNV and/
or JEV, which can lead to misdiagnosis as most of the symptoms 
overlap. These viruses present as a flu-like illness characterized 
by fever, myalgia, headache, gastrointestinal disturbance, and 
maculopapular rash. Up to 1% of WNV-/JEV-infected individu-
als may show neuroinvasive disease (34, 35). Clinical features 
like headache, altered mental status, GI distress, limb weakness, 
and motor neuron disease pattern with flaccid paralysis are 
clues to the diagnosis of CNS infection with WNV or JEV (34, 
35). Over a third of WNV-confirmed patients here had clinical 
features consistent with neuroinvasive disease. WNV-exposed 
patients exhibited unique symptoms when compared to JEV. 
WNV-infected individuals were much more likely to exhibit 
altered mental status, reduced Glasgow Coma scores, encepha-
litis, and seizure activity, whereas persons with JEV infection 
were more likely to suffer from nausea, thrombocytopenia, and 
be male.
The data show that average summer temperatures correlated 
with human WNV incidence. Mosquito numbers and human 
WNV infections and precipitation were also directly correlated. 
It was during this time that WNV was detected in a pool of Culex 
spp., via RT-PCR, which suggests that active WNV transmission 
was occurring. These findings are concordant with similar reports 
in Europe (35, 36). The city of Karachi is an ideal urban environ-
ment for Culex spp. propagation and transmission. The city has 
vectors, hosts, and an abundance of standing water with sewage or 
other organic material that enhance larval propagation (37–39). 
The low numbers of Aedes and Anopheles spp. collected was most 
likely due to our trapping methods. No trapping occurred dur-
ing the daytime when Aedes mosquitoes are active and CO2 or 
other baits for attracting Anopheles were not used (40). Further 
surveillance of larger geographical areas along with larval and 
pupal demographic surveys are required to assess overall picture 
of the various mosquito species in Karachi.
A major limitation of this study was that only patient serum 
was tested via RT-PCR for the presence of virus. Since the incep-
tion of this study, research in molecular diagnostics of clinical 
specimens has determined that whole blood and urine are more 
useful for detecting WNV in human patients (41). Another 
limitation of the study is that vector surveillance was conducted 
in a small geographic region of Karachi (0.34 km2), and sentinel 
animals were not used. Despite these limitations, our results can 
be generalized as most of Karachi has similar features in terms of 
mosquito propagation sites, avian fauna, and susceptible human 
population.
Detection of vectors and humans infected with WNV is 
suggestive of a competent enzootic cycle. The climatic and 
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sanitation conditions in Karachi are supportive of active 
propagation and dissemination of vectors and consequent risk 
of an epidemic outbreak of this virus. Active disease surveil-
lance and preventive strategies are not available in Pakistan 
but are urgently needed at regional and national levels to 
prevent such from happening in timely manner. Moreover, 
there is as a great need for the standardization of diagnostic 
assays and procedures, more accurate diagnostic assays, 
and renovated diagnostic algorithms for Pakistan and other 
countries where WNV co-circulates with other flaviviruses. 
While development of surveillance networks, diagnostic 
assays, and standardized procedures can be overwhelming for 
developing countries, it is rapidly becoming apparent that the 
long-term costs to public health are greater in the face of fla-
vivirus disease. Given the high seroprevalence of flaviviruses, 
reinstitution of DEWS or similar program should be seriously 
considered for Pakistan.
Regardless, the findings of this study are an alert for physi-
cians to suspect WNV infection in patients with altered mental 
status and other neurological symptoms in a dengue-like illness 
in patients inhabiting or traveling to and from Pakistan, especially 
during the late summer and autumn months. WNV-associated 
neuroinvasive disease is an important differential diagnosis for 
other neurological diseases such as poliovirus currently circulat-
ing in Pakistan.
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